• Mycoplasma pneumoniae causes pneumonia predominantly in school-aged children and young adults.
Introduction
Mycoplasma pneumoniae colonizes the upper respiratory tract [1] and causes pneumonia predominantly in school-aged children and young adults [2] . In contrast, other mycoplasmas and ureaplasmas colonize the urogenital tract, among which M. hominis, U. urealyticum, and U. parvum may cause ascending intrauterine infection that can lead to adverse pregnancy outcomes and/or B.M.H. and P.M.M.S. contributed equally to this work. neonatal pneumonia [3, 4] . Here, we present a preterm infant with severe neonatal M. pneumoniae pneumonia acquired by vertical infection.
Congenital Mycoplasma pneumoniae Infection

Case Report
A preterm male neonate weighing 1,500 g was delivered by a 30-year-old woman at 29 4/7 weeks of gestation by cesarean section because of recurrent vaginal bleedings and premature contractions for 3 days. Antenatal steroid administration had been completed. The Apgar score was 2, 4, and 9 at 1, 5, and 10 min, respectively, and the umbilical artery pH was 7.31. He developed a severe respiratory distress syndrome (RDS) in the first hour of life requiring mechanical ventilation and surfactant administration. Chest X-ray showed a granular appearance of both lungs with air bronchograms (Fig. 1a) . Empiric antibiotic treatment with amoxicillin and gentamicin was immediately started. After 24 h, extubation was achieved and followed by nasal continuous positive airway pressure treatment. Antibiotic treatment was discontinued based on negative blood cultures and C-reactive protein within the normal range. Secondary respiratory distress developed on the second day of life (DOL) and necessitated re-intubation until DOL 4 and again from DOL 6 to 11. Chest X-ray on DOL 6 revealed multifocal opacifications and consolidations (Fig. 1b) . Because of the atypical RDS presentation, an extensive diagnostic workup was performed: cultures from blood and tracheal aspirate were repeatedly negative for bacteria, as well as for fungi, as were cultures from urine for cytomegalovirus. There were no signs and symptoms of multiorgan involvement. Blood cell count showed a leukocytosis of 41 × 10 9 /L after birth, which increased to a maximum of 97 × 10 9 /L on DOL 2 and consisted of mainly neutrophils, including immature granulocytes. There was no evidence of leukemia or transient myeloproliferative disorder. C-reactive protein remained normal over the course of disease.
The unclear situation led to a detailed review of the medical history during pregnancy: the mother recalled a mild respiratory tract infection with intractable cough at 20 gestational weeks lasting for a week, but this was left untreated. The diagnostic workup in the neonatal tracheal aspirate was extended by M. pneumoniaespecific PCR as previously described [5] : M. pneumoniae DNA could be detected in tracheal aspirate on DOL 3 and in a second sample from nasopharyngeal aspirate after extubation on DOL 4. No DNA of M. hominis, M. genitalium, or Ureaplasma spp. was found in the tracheal aspirate by PCR, performed as described previously [6, 7] . Treatment with erythromycin was initiated orally on DOL 4 (50 mg/kg/dose 4 times a day) and switched to intravenous application from DOL 7 to DOL 18 (40 mg/kg/dose 4 times a day). Erythromycin treatment was paralleled by a steady and sustainable improvement of clinical and radiographic findings. Chest X-ray on DOL 9 returned almost to normal. On DOL 22, the white blood cell count was normal and serological testing using an enzymelinked immunosorbent assay (Serion GmbH, Würzburg, Germany) revealed M. pneumoniae-specific immunoglobulin (Ig) M and IgG antibodies of < 5 U/mL (cutoff 17 U/mL) and 65 U/mL (cutoff 15 U/mL), respectively. Nasal continuous positive airway pressure treatment was followed until DOL 23 and supplemental oxygen administered until DOL 30, defining mild bronchopulmonary dysplasia. The infant was discharged with 8 weeks of age at 37 6/7 weeks postmenstrual age. A 1-month follow-up was uneventful.
Maternal serum obtained 2 weeks after birth was tested positive for M. pneumoniae-specific IgM (93 U/mL; cutoff 17 U/mL) and IgG (> 200 U/mL; cutoff 30 U/mL), indicating a recent infection. Prepartal maternal swabs from the cervix uteri were negative by PCR for DNA of Chlamydia trachomatis and Neisseria gonorrhoeae, and also vaginal swab cultures were negative. Histological examination of the placenta showed distinct chorioamnionitis and vasculitis with infiltration of neutrophils into the chorioamniotic mesoderm layer and amnion (Fig. 1c, e) . Placental tissues embedded in paraffin were tested positive for M. pneumoniae DNA by PCR and M. pneumoniae antigens by immunohistochemistry (Fig. 1d, f ). Placental tissue was tested negative for DNA of Ureaplasma spp., M. hominis, and M. genitalium by PCR. Control placental tissues without chorioamnionitis and chorioamnionitis of other origin were tested negative for M. pneumoniae antigens by immunohistochemistry (data not shown).
Discussion
Congenital pneumonia arises from direct mucosal seeding from infected amniotic fluid (chorioamnionitis), which is caused by hematogenous transplacental infection or ascending infection across the chorioamniotic membranes [8] . Maternal vaginal colonization is a key risk factor for an ascending intrauterine infection and/or perinatal infection during passage through the birth canal [8] . Mycoplasmas are primarily mucosal pathogens, among which genital mycoplasmas and ureaplasmas colonize the urogenital tract. M. hominis, U. urealyticum, and U. parvum are also associated with neonatal pneumonia [3, 4] . In contrast, M. pneumoniae is known to exclusively colonize the respiratory tract [3] . The question arises whether chorioamnionitis in our case was caused by a so far not reported ascending infection or rather by spread from respiratory tract infection through the bloodstream to the placenta. In line with the latter, M. pneumoniae has been reported to disseminate in the bloodstream during or after a respiratory tract infection and to cause extrapulmonary manifestations [9] [10] [11] [12] . The mother indeed experienced a cough around 8 weeks before birth and the serology after birth confirmed a recent M. pneumoniae infection. This respiratory infection may have led to invasive infection and spread of M. pneumoniae to the placenta. In fact, infections with M. hominis, U. urealyticum, or U. parvum as potential cause of adverse pregnancy outcome and/or neonatal pneumonia were excluded. Thus, the diagnosis of vertical M. pneumoniae infection in our case is established as follows: (1) [10] , and vertical transmission of M. pneumoniae infection has been very rarely reported. To our knowledge, 3 cases of neonatal pneumonia associated with M. pneumoniae have been published so far (Table 1) [13] [14] [15] . Vertical transmission of M. pneumoniae infection has been suggested in 2 preterm neonates with either rapidly or slowly progressing respiratory failure requiring mechanical ventilation immediately after birth. A vertical route of transmission was confirmed in 1 case with the detection of M. pneumoniae DNA by PCR in placental tissue. We additionally showed by immunohistochemical analysis that M. pneumoniae is present in the placenta.
Interestingly, anti-M. pneumoniae IgG, but not IgM, was detected in the neonate on DOL 22. The detection of specific IgG is complicated by transplacental transfer of maternal antibodies. In contrast, the detection of IgM is very specific to the fetal compartment because IgM does not cross the placenta. However, the neonate's immune system may not mount an antibody response as effective as adults [16] , and, most importantly, a negative IgM result does not exclude congenital infection [17, 18] . Further, the antibody response to M. pneumoniae is complex [19] . We present only the second case of neonatal pneumonia associated with M. pneumoniae, in which the antibody response was assessed (Table 1) . One might speculate that the presence or absence of M. pneumoniae-specific IgM may discriminate between perinatal infection after birth (case 3, Table 1 ) and congenital infection (present case).
This case demonstrates that M. pneumoniae can be considered as possible cause of congenital pneumonia in addition to other "atypical" organisms. The route of transmission of M. pneumoniae is vertical infection after dissemination of the bacteria following maternal respiratory tract infection. Chorioamnionitis likely induced premature birth, but it remains unclear whether M. pneumoniae triggered also bronchopulmonary dysplasia as reported for ureaplasmas. 
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